Thursday - January 22, 2026
Royal Marsden National Health Service Foundation Trust: Lifesaving Drug, Abiraterone, Now Approved for Men With High-risk Prostate Cancer in England
January 21, 2026
LONDON, England, Jan. 21 -- The Royal Marsden National Health Service Foundation Trust issued the following news:

* * *

Lifesaving drug, abiraterone, now approved for men with high-risk prostate cancer in England

Evidence for the approval came from the STAMPEDE trial, led by The Royal Marsden's Professor Nicholas James

*

Abiraterone was discovered by The Institute of Cancer Research, London and The Royal Marsden NHS Foundation . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products